ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.52
-0.17%
US Tech 100
17,561.20
-0.23%
S&P 500
5,187.67
0.00%
US Dollar vs CAD
1.37315
0.03%
Bitcoin
61,389.64
0.33%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Eyegate Pharmaceuticals Inc (EYEGW)

  7. Eyegate Pharmaceuticals Inc (EYEGW) News

EYEGW

Eyegate Pharmaceuticals (EYEGW)

Eyegate Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EYEGW
DateTimeSourceHeadlineSymbolCompany
09/21/20167:30AMGlobeNewswire Inc.EyeGate Pharmaceuticals to Present at the 2016 Aegis Capital ConferenceNASDAQ:EYEGWEyegate Pharmaceuticals Inc
09/13/20167:30AMGlobeNewswire Inc.EyeGate Awarded $448,185 for second year of funding of Phase II SBIR Grant from U.S. Department of DefenseNASDAQ:EYEGWEyegate Pharmaceuticals Inc
09/12/20167:30AMGlobeNewswire Inc.EyeGate Receives Additional Milestone Payment from Valeant Pharmaceuticals for EGP-437NASDAQ:EYEGWEyegate Pharmaceuticals Inc
09/06/20167:30AMGlobeNewswire Inc.EyeGate Pharmaceuticals to Present at the 18th Annual Rodman and Renshaw Global Investment ConferenceNASDAQ:EYEGWEyegate Pharmaceuticals Inc
08/10/20163:50PMGlobeNewswire Inc.EyeGate Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business UpdateNASDAQ:EYEGWEyegate Pharmaceuticals Inc
08/01/20167:30AMGlobeNewswire Inc.EyeGate Announces Positive Top-line Data from Phase 1b/2a Clinical Trial of EGP-437 for Treatment of Post-Operative Inflammat...NASDAQ:EYEGWEyegate Pharmaceuticals Inc
06/30/201612:00PMGlobeNewswire Inc.EyeGate Announces Completion of $3.77 Million Registered Direct OfferingNASDAQ:EYEGWEyegate Pharmaceuticals Inc
06/27/20167:00AMGlobeNewswire Inc.EyeGate Announces $3.77 Million Registered Direct OfferingNASDAQ:EYEGWEyegate Pharmaceuticals Inc
06/01/20167:30AMGlobeNewswire Inc.EyeGate Announces Encouraging Interim Data from Phase 1b/2a Clinical Trial of EGP-437 for Treatment of Ocular Inflammation an...NASDAQ:EYEGWEyegate Pharmaceuticals Inc
05/24/20165:00PMGlobeNewswire Inc.EyeGate Pharma Announces At The Market Issuance ProgramNASDAQ:EYEGWEyegate Pharmaceuticals Inc
05/13/20164:25PMGlobeNewswire Inc.Eyegate Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Business UpdateNASDAQ:EYEGWEyegate Pharmaceuticals Inc
05/06/20167:30AMGlobeNewswire Inc.EyeGate Pharma Appoints Dr. Brenda K. Mann as Vice President, Research and DevelopmentNASDAQ:EYEGWEyegate Pharmaceuticals Inc
04/28/201610:46AMGlobeNewswire Inc.EyeGate Pharma to Present Four Posters at ARVO 2016 Annual Meeting Supporting Development of CMHA-SNASDAQ:EYEGWEyegate Pharmaceuticals Inc
04/27/20163:05PMGlobeNewswire Inc.EyeGate Pharma Appoints Ryan R. Brenneman as Chief Financial OfficerNASDAQ:EYEGWEyegate Pharmaceuticals Inc
03/29/20163:45PMGlobeNewswire Inc.EyeGate Reports Full-year 2015 Financial Results and Provides Business UpdateNASDAQ:EYEGWEyegate Pharmaceuticals Inc
03/09/20166:46PMGlobeNewswire Inc.EyeGate Pharma Acquires Jade TherapeuticsNASDAQ:EYEGWEyegate Pharmaceuticals Inc
03/09/20166:46PMGlobeNewswire Inc.EyeGate Receives Additional Milestone Payment From Valeant Pharmaceuticals for EGP-437NASDAQ:EYEGWEyegate Pharmaceuticals Inc
01/19/20167:30AMGlobeNewswire Inc.EyeGate Pharma Enrolls First Patient in Confirmatory Phase 3 Clinical Trial EGP-437-006 for Non-Infectious Anterior UveitisNASDAQ:EYEGWEyegate Pharmaceuticals Inc
01/14/20168:49AMGlobeNewswire Inc.Eyegate Pharmaceuticals to Present at the Noble Financial Capital Markets’ 12th Annual Investor ConferenceNASDAQ:EYEGWEyegate Pharmaceuticals Inc
11/12/20157:30AMGlobeNewswire Inc.EyeGate Reports Third Quarter 2015 Financial Results and Provides Business UpdateNASDAQ:EYEGWEyegate Pharmaceuticals Inc
11/05/20157:45AMGlobeNewswire Inc.EyeGate Announces Interim Data From Phase 1b / 2a Clinical Trial of Iontophoretic EGP-437 Ophthalmic Solution in Macular Edem...NASDAQ:EYEGWEyegate Pharmaceuticals Inc
10/15/20157:30AMGlobeNewswire Inc.EyeGate Pharma Receives USPTO Notice of Allowance for Next Generation of Proprietary Iontophoretic Delivery SystemNASDAQ:EYEGWEyegate Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:EYEGW

Your Recent History

USOTC
BMXI
Brookmount Explorations (PK)
USOTC
RONN
Ronn Motor (PK)
NASDAQ
HOLO
MicroCloud Hologram
USOTC
GSTC
Globestar Therapeutics (PK)
USOTC
KGKG
Kona Gold Beverage (PK)
USOTC
BIEL
Bioelectronics (PK)
USOTC
FLES
Auto Parts 4Less (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
ILST
International Star (PK)
USOTC
KEGS
1812 Brewing (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
PSRU
Valiant Eagle (PK)
USOTC
TKMO
Tekumo (PK)
USOTC
IPIX
Innovation Pharmaceuticals (CE)
NASDAQ
PLUG
Plug Power
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved